Thermal analysis of anhydrous and hydrated Cholesterol

Cholesterol constitutes the major component of most gallstones. It was identified and determined, in gallstones, issued from eleven patients, by thermal analysis: differential scanning calorimetry (DSC), with the use of the melting temperature and enthalpy, thermogravimetry (TG), with the mass loss of water. Anhydrous cholesterol (ChA) was characterized by two endothermic peaks (polymorphic, melting) and cholesterol monohydrate (ChH) by two endothermic peaks (dehydration, melting), too. Cha needle and Chh plate crystals were observed under polarizing light microscopy. The numerous stones obtained from nine patients were cholesterol stones: the ChA was higher 45 and lower 96%. ChH was present in stones of three patients. This revised version was published online in July 2006 with corrections to the Cover Date.     

磁共振方法研究12-钨磷酸水合物中水分子的运动状态

本文使用以Cu(Ⅱ)为顺磁探针的ESR以及宽谱线~1H-NMR等磁共振方法,研究了12-钨磷酸水合物中水分子的运动状态,结果表明水合水的活动性不仅取决于温度,而且还与12-钨磷酸水合物中的含水量有关。     

X-ray diffraction/Calorimetry coupling

Polymorphism of trilaurin mixed with 4% of cholesterol was studied with a setup coupling calorimetry and phase characterisation by in-situ X-ray diffraction (Microcalix). Four polymorphic forms were identified. Monotropic and enantiotropic transitions were identified from the reconstruction of Gibbs free energy diagram which allows the control of trilaurin polymorphism. This revised version was published online in July 2006 with corrections to the Cover Date.     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

24ζ-甲基-20 S-胆甾醇的合成

已发现的天然甾醇均为20R 构型。近年来在地质体中发现了具有20S 构型的甾烷类生物标志化合物,并称之为地质构型。合成20S 构型的甾烷的方法之一是由20S 构型的甾醇为原料。20S-胆甾醇及20S-胆甾烷的合成已有报道,但24ξ-甲基-20S-     

Formation and Structure of [Al_(13)(μ_3-OH)_6(μ_2-OH)_6(μ_2-OH)_(12)(H_2O)_(24)]Cl_(15)·13H_2O

1 INTRODUCTION At present, the polyaluminium compounds are mainly studied by single-crystal X-ray diffraction method to obtain the components, structures and exis- tence forms of aluminium in hydrolysis system, and then hydrolysis courses and mechanisms of each hydrolytic polyaluminium cation could be further dis- closed[1～5]. Generally, the single crystals suitable for X-ray diffraction are obtained from the crystallization of polyaluminium cations into sulfates or selenates. Following …     

磷脂水解与胆固醇型胆结石时的可能生成机理

用胆酸盐-磷脂-胆固醇-水体系模拟胆汗的化学行为。在体系中发现，磷脂可 以发生降解形成脂肪酸。而在胆汗中，磷脂在增溶固醇的过程中起到了十分重要的 作用。依此，我们提出磷脂的水解可能与胆固醇型胆结石的生成有密切关系。     

Lecithin/propanol-based microemulsions used as media for a cholesterol oxidase-catalyzed reaction

Reverse micelles, Winsor III and IV systems were examined as reaction media for the enzymatic conversion of cholesterol to cholestenone by cholesterol oxidase at 298.2 K. The micelles and the microemulsions, stabilized by soybean lecithin and ethanol or 1-propanol as cosolvent, were characterized with respect to phase behavior and distribution of 1-propanol between the phases of the Winsor III systems. The used oils were dodecane, tetradecane, and hexadecane. The Winsor IV systems and the surfactant-rich phase in the Winsor III systems exhibit bicontinuous structures. The reaction yield for the enzymatic conversion performed in a Winsor IV system was much higher than in a Winsor III system or in reverse micelles.     

Thermal analysis and microscopical characterization of cholesterol in gallstones

Summary Cholesterol constitutes the major component of most gallstones. It was identified and determined in gallstones by thermal analysis technique (DSC and TG-DTA), mainly by the use of the melting temperature (T_onset=145°C and T_max=149°C) and by DTG peak decomposition (T_max=364°C). Cholesterol anhydrous (ChA), which showed endothermic polymorphic peak, T_max=40°C, without mass loss, was differentiated from cholesterol monohydrate (ChH), which showed a broad endothermic peak, T_max=59°C, attributed to loss of water of crystallization (theoretical 4.45%). Morphological studies of gallstones were performed by optical microscopy and scanning electron microscopy (SEM). The stones consisted of a pigmented core with a variably-sized irregular central cavity, surrounded by a radially arranged deposits of plate-like ChH. The outer part of the stones showed ChA crystal arborescences. X-ray microanalysis gave a typical spectrum rich in C and O, and in some instances the presence of P, which was attributed to the presence of phospholipids. CaCO₃ was easily characterized by TG with the use of DTG decomposition peak at 674°C.     

ImmobilizedE. coli Alkaline Phosphatase

We have immobilized E.coli alkaline phosphatase (EC 3.1.3.1) by linking it covalently to sepharose 4B. This preparation has several advantages over the soluble enzyme. The immobilized enzyme is easily separable from other constituents in incubation mixtures. The immobilized enzyme can be reused repeatedly and is more stable than the soluble enzyme to heat treatment in the presence of 10 mM Mg²⁺. The insoluble and soluble phosphatases removed 75 and77%, respectively, of the inorganic phosphorus from casein. The immobilized enzyme inactivated two enzymes believed to be active in the phosphorylated state, acyl-CoA : cholesterol acyltransferase (ACAT) by 39% and NADPH-cytochrome P-450 reductase by 89%. The utility of immobilized alkaline phosphatase for studying the phosphorylation and dephosphorylation of soluble or membrane-bound enzymes and proteins is discussed.